Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zeynab Fakhar, Suhashni Naiker, Claudio N. Alves, Thavendran Govender, Glenn E.M. Maguire, Jeronimo Lameira, Gyanu Lamichhane, Hendrik G. Kruger & Bahareh Honarparvar. (2016) A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis. Journal of Biomolecular Structure and Dynamics 34:11, pages 2399-2417.
Read now
Read now
Y. Nishiya, K. Nakamura, N. Okudaira, K. Abe, N. Kobayashi & O. Okazaki. (2010) Effects of organic solvents on the time-dependent inhibition of CYP3A4 by diazepam. Xenobiotica 40:1, pages 1-8.
Read now
Read now
Y. Nishiya, K. Hagihara, A. Kurihara, N. Okudaira, N.A. Farid, O. Okazaki & T. Ikeda. (2009) Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. Xenobiotica 39:11, pages 836-843.
Read now
Read now
Hans-Ulrich Demuth. (1990) Recent Developments in Inhibiting Cysteine and Serine Proteases. Journal of Enzyme Inhibition 3:4, pages 249-278.
Read now
Read now
Articles from other publishers (35)
Robert A. Copeland. 2023. Enzymes. Enzymes
371
399
.
DAN A. ROCK & LARRY C. WIENKERS. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
465
526
.
Sida Shen, Peter F. Doubleday, Pathum M. Weerawarna, Wei Zhu, Neil L. Kelleher & Richard B. Silverman. (2020) Mechanism-Based Design of 3-Amino-4-Halocyclopentenecarboxylic Acids as Inactivators of GABA Aminotransferase. ACS Medicinal Chemistry Letters 11:10, pages 1949-1955.
Crossref
Crossref
Michael V. Fiandalo, Daniel T. Gewirth & James L. Mohler. (2019) Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer. Asian Journal of Urology 6:1, pages 50-56.
Crossref
Crossref
Hui Dong, Qingqing Han, Yu Guo, Jiansong Ju, Shanshan Wang, Chao Yuan, Wei Long, Xin He, Shujing Xu & Sheng Li. (2018) Enzymatic characterization and crystal structure of biosynthetic alanine racemase from Pseudomonas aeruginosa PAO1. Biochemical and Biophysical Research Communications 503:4, pages 2319-2325.
Crossref
Crossref
Hui Dong, Tingting Hu, Guangzheng He, Deren Lu, Jianxun Qi, Yanshu Dou, Wei Long, Xin He, Jiansong Ju & Dan Su. (2018) Structural features and kinetic characterization of alanine racemase from Bacillus pseudofirmus OF4. Biochemical and Biophysical Research Communications 497:1, pages 139-145.
Crossref
Crossref
Darrell D. Marshall, Steven Halouska, Denise K. Zinniel, Robert J. Fenton, Katie Kenealy, Harpreet K. Chahal, Govardhan Rathnaiah, Raúl G. Barletta & Robert Powers. (2017)
Assessment of Metabolic Changes in
Mycobacterium smegmatis
Wild-Type and
alr
Mutant Strains: Evidence of a New Pathway of
d
-Alanine Biosynthesis
. Journal of Proteome Research 16:3, pages 1270-1279.
Crossref
Crossref
Xiaoliang Sun, Guangzheng He, Xiaoyan Wang, Shujing Xu, Jiansong Ju & Xiaoling Xu. (2015) Crystal Structure of a Thermostable Alanine Racemase from Thermoanaerobacter tengcongensis MB4 Reveals the Role of Gln360 in Substrate Selection. PLOS ONE 10:7, pages e0133516.
Crossref
Crossref
Honggang Zhou, Zhenzhen Li, Guofang Zhang, Shujing Xu, Zhaona Tang, Xianming Zhu, Hui Dong & Jiansong Ju. (2014)
Crystallization and preliminary X-ray study of biosynthetic alanine racemase from
Pseudomonas aeruginosa
PAO1
. Acta Crystallographica Section F Structural Biology Communications 70:12, pages 1616-1619.
Crossref
Crossref
Oluwatoyin A. Asojo, Sarah K. Nelson, Sara Mootien, Yashang Lee, Wanderson C. Rezende, Daniel A. Hyman, Monica M. Matsumoto, Scott Reiling, Alan Kelleher, Michel Ledizet, Raymond A. Koski & Karen G. Anthony. (2014)
Structural and biochemical analyses of alanine racemase from the multidrug-resistant
Clostridium difficile
strain 630
. Acta Crystallographica Section D Biological Crystallography 70:7, pages 1922-1933.
Crossref
Crossref
Yashang Lee, Sara Mootien, Carolyn Shoen, Michelle Destefano, Pier Cirillo, Oluwatoyin A. Asojo, Kacheong R. Yeung, Michel Ledizet, Michael H. Cynamon, Paul A. Aristoff, Raymond A. Koski, Paul A. Kaplan & Karen G. Anthony. (2013) Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones. Biochemical Pharmacology 86:2, pages 222-230.
Crossref
Crossref
Zhangwei Xue, Yi Hu, Shujing Xu, Kouhei Ohnishi, Yanhe Ma, Jiansong Ju & Baohua Zhao. (2013) Characterization and preliminary mutation analysis of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Extremophiles 17:4, pages 611-621.
Crossref
Crossref
Hui Dong, Shujing Xu, Xiaoyun Lu, Guangzheng He, Ranran Zhao, Shuai Chen, Sheng Fu & Jiansong Ju. (2013)
Crystallization and preliminary X-ray study of a thermostable alanine racemase from
Thermoanaerobacter tengcongensis
MB4
. Acta Crystallographica Section F Structural Biology and Crystallization Communications 69:6, pages 660-662.
Crossref
Crossref
Alexander V. LyubimovMelissa A. Kramer & Timothy S. Tracy. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
25
.
David A Bender. 2012. Amino Acid Metabolism. Amino Acid Metabolism
105
128
.
Alexander V. LyubimovDeepak K. Dalvie & Cho‐Ming Loi. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Alexander V. LyubimovDeepak K. Dalvie. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
54
.
Han-Chul Kang, Sang-Hong Yoon, Chang-Muk Lee & Bon-Sung Koo. (2011) Biochemical Characteristics of an Alanine Racemase from Xanthomonas oryzae pv. oryzae. Journal of Applied Biological Chemistry 54:4, pages 231-237.
Crossref
Crossref
Hookang Im, Miriam L Sharpe, Ulrich Strych, Milya Davlieva & Kurt L Krause. (2011) The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiology 11:1.
Crossref
Crossref
Dan Rock & Larry C. Wienkers. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
56
.
Rafael M Couñago, Milya Davlieva, Ulrich Strych, Ryan E Hill & Kurt L Krause. (2009) Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames). BMC Structural Biology 9:1.
Crossref
Crossref
Yumi Nishiya, Katsunobu Hagihara, Takashi Ito, Masami Tajima, Shin-ichi Miura, Atsushi Kurihara, Nagy A. Farid & Toshihiko Ikeda. (2009) Mechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of Prasugrel. Drug Metabolism and Disposition 37:3, pages 589-593.
Crossref
Crossref
Dan Rock & Larry C. Wienkers. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
479
534
.
David Kopečný, Marek Šebela, Pierre Briozzo, Lukáš Spíchal, Nicole Houba-Hérin, Vlastimil Mašek, Nathalie Joly, Catherine Madzak, Pavel Anzenbacher & Michel Laloue. (2008) Mechanism-Based Inhibitors of Cytokinin Oxidase/Dehydrogenase Attack FAD Cofactor. Journal of Molecular Biology 380:5, pages 886-899.
Crossref
Crossref
Daniel L. Milligan, Sieu L. Tran, Ulrich Strych, Gregory M. Cook & Kurt L. Krause. (2007)
The Alanine Racemase of
Mycobacterium smegmatis
Is Essential for Growth in the Absence of
d
-Alanine
. Journal of Bacteriology 189:22, pages 8381-8386.
Crossref
Crossref
Andrew C. EliotJack F. Kirsch. (2004) Pyridoxal Phosphate Enzymes: Mechanistic, Structural, and Evolutionary Considerations. Annual Review of Biochemistry 73:1, pages 383-415.
Crossref
Crossref
Angelika Muscate, Cynthia L. Levinson & George L. Kenyon. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Tristan S. Maurer, Mohammad A. Tabrizi‐Fard & Ho‐Leung Fung. (2000) Impact of mechanism‐based enzyme inactivation on inhibitor potency: Implications for rational drug discovery. Journal of Pharmaceutical Sciences 89:11, pages 1404-1414.
Crossref
Crossref
Tsuyoshi Ohba, Eitatsu Ikeda, Naoki Tsuchiya, Kuniko Nishimura & Hisashi Takei. (1996) Mechanism-based inactivation of serine proteases by dichlorocyclopropane fused lactone derivatives. Bioorganic & Medicinal Chemistry Letters 6:22, pages 2629-2634.
Crossref
Crossref
K. Hoffmann, E. Schneider-Scherzer, H. Kleinkauf & R. Zocher. (1994) Purification and characterization of eucaryotic alanine racemase acting as key enzyme in cyclosporin biosynthesis.. Journal of Biological Chemistry 269:17, pages 12710-12714.
Crossref
Crossref
A Nangia. (1993) AM1 heats of formation for the reaction of alcohols with a series of β-lactams and aza-β-lactams: Design of novel β-lactamase inactivators. Proceedings / Indian Academy of Sciences 105:2, pages 131-139.
Crossref
Crossref
Raymond T. Cunningham, Suzanne E. Mangold, Lyle W. Spruce, Qi Long Ying, Sanford R. Simon, Maciej Wieczorek, Sherman Ross, John C. Cheronis & Gary P. Kirschenheuter. (1992) Synthesis and evaluation of CE-0266: A new human neutrophil elastase inhibitor. Bioorganic Chemistry 20:4, pages 345-355.
Crossref
Crossref
R.F. Pratt. (1992) On the definition and classification of mechanism-based Enzyme Inhibitors. Bioorganic & Medicinal Chemistry Letters 2:11, pages 1323-1326.
Crossref
Crossref
Gunda U. Georg & Xiangming Guan. (1992) Asymmetric synthesis of ?-alkylated ?-amino acids: azocane-2-carboxylic acids. Tetrahedron Letters 33:1, pages 17-20.
Crossref
Crossref
Ashwini Nangia. (1991) AM1 calculations on a series of bicyclic azetidin-2-ones and bicyclic 1,3-diazetidin-2-ones: investigations towards putative ?-lactamase inactivators. Journal of Molecular Structure: THEOCHEM 251, pages 237-243.
Crossref
Crossref